|
⚲
|
| Keyboard |
| Jonathan Behr | |
|---|---|
| Firm | |
| Address | 71 Kingsway London, X0 WC2B 6ST |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Violet Therapeutics Inc | 021-480940 | Director | 7.4 M of 11.5 M |
||
| Quralis Corp | 021-457747 | Director | 5.0 M of 10.0 M |
||
| Endlyz Therapeutics Inc | 021-408116 | Director | 3.2 M of 6.5 M |
||
| Quralis Corp | 021-367164 | Director | 33.2 M of 60.0 M |
||
| Nitrome Biosciences Inc | 021-365579 | Director | 17.1 M of 47.5 M |
||
| Immunomolecular Therapeutics Inc | 021-342324 | Director | 3.0 M of 10.0 M |
||
| Veralox Therapeutics Inc | 021-340135 | Director | 1.5 M of 4.0 M |
||
| SV Health Managers LLP | |||||
| Dementia Discovery Fund 2 LP | 021-438433 | Executive Officer | 201.7 M of 350.0 M |
252.3 M | |